TribLIVE

| Opinion/The Review

 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

ADHD questions: Pharma crock?

Email Newsletters

Click here to sign up for one of our email newsletters.

Letters home ...

Traveling abroad for personal, educational or professional reasons?

Why not share your impressions — and those of residents of foreign countries about the United States — with Trib readers in 150 words?

The world's a big place. Bring it home with Letters Home.

Contact Colin McNickle (412-320-7836 or cmcnickle@tribweb.com).

Daily Photo Galleries

'American Coyotes' Series

Traveling by Jeep, boat and foot, Tribune-Review investigative reporter Carl Prine and photojournalist Justin Merriman covered nearly 2,000 miles over two months along the border with Mexico to report on coyotes — the human traffickers who bring illegal immigrants into the United States. Most are Americans working for money and/or drugs. This series reports how their operations have a major impact on life for residents and the environment along the border — and beyond.

Thursday, Dec. 19, 2013, 8:55 p.m.
 

The dubious notion of “better living through pharmacology” should be questioned even more closely regarding the attention deficit hyperactivity disorder industry.

Historically, ADHD, as it's better known, affects an estimated 5 percent of children. Yet recent Centers for Disease Control and Prevention data show 15 percent of high school-age children diagnosed with ADHD, and 3.5 million children — up from 600,000 in 1990 — on ADHD drugs. Analyzing that data, The New York Times finds ADHD now “narrowly trailing” only asthma among most frequent long-term diagnoses in children.

The Times says marketing stretches ADHD “to include relatively normal behavior like carelessness and impatience” and “has often overstated the pills' benefits.” Since 2000, the Food and Drug Administration has cited “every major” ADHD drug “for false and misleading” ads.

Online quizzes encourage ADHD treatment. Celebrities are paid to endorse ADHD drugs, doctors to push particular brands to colleagues; ads boost medical journals' page counts. ADHD materials are placed in schools. And drug makers increasingly target the far larger adult market.

It's time to question whether the ADHD industry's growth is a matter of genuinely better diagnosis and treatment — or of overdiagnosis, overprescription and downplaying ADHD drugs' abuse/addiction potential and side effects.

But the most basic question to be answered is whether the entrenched pharmacology-medical complex truly leads to better living or not.

Subscribe today! Click here for our subscription offers.

 

 


Show commenting policy

Most-Read Editorials

  1. The Export-Import Bank: The Senate’s shame
  2. Pittsburgh Tuesday takes
  3. Greensburg Tuesday takes
  4. Alle-Kiski Tuesday takes
  5. At the VA: The waiting dead
  6. Yes, the IRS targeted conservatives
  7. U.N. Watch: The ‘race’ is on
  8. Council fails again: Shoot straight, Ford City
  9. The wind ruse: A failed policy
  10. Sunday pops
  11. The Keystone XL pipeline: No surrender